Innate immunity in surgical patients

Chirurgia (Romania)

Volumn 108, Issue 1, 2013, Pages 18-25

  Lacatus, M ^a  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

Author keywords

Acute phase reaction; Endotoxin tolerance; Innate immunity; MicroRNA; Sepsis; Splenectomy; Toll like receptors

Indexed keywords

EID: 84878291953     PISSN: 12219118     EISSN: 1842368X     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. Philadelphia: Elsevier Saunders; 2012.
2. Current Topics in Innate Immunity. Philadelphia: Springer; 2007.
3. The Cytokine Handbook. San Diego: Elsevier Science; 2003.
4. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20: 197-216. Epub 2001 Oct 4.
5. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11(5): 373-84. doi: 10.1038/ni.1863. Epub 2010 Apr 20.
6. Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun. 2009;388(4): 621-5.
7. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6): 805-20.
8. Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature. 2008;452(7184): 234-8.
9. Vasilescu C, Olteanu M, Flondor P. How relevant are in vivo and in vitro studies for clinical sepsis? A mathematical model of LPS signaling based on endotoxin tolerance. Chirurgia (Bucur). 2009;104(2): 195-201.
10. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O et al. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood. 1995;85(5): 1341-7.
11. Du T, Zamore PD. Beginning to understand microRNA function. Cell Res. 2007;17(8): 661-3.
12. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1): 15-20.
13. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008;455: 58-63.
14. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006 Aug 15;103(33): 12481-6. Epub 2006 Aug 2.
15. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A. 2007;104(5): 1604-9. Epub 2007 Jan 22.
16. Calin GA, Vasilescu C, Negrini M, Barbanti-Brodano G. Genetic chaos and antichaos in human cancers. Med Hypotheses. 2003;60(2): 258-62.
17. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10(10): 704-14.
18. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010;327(5962): 198-201.
19. Beutler B. SHIP, TGF-beta, and endotoxin tolerance. Immunity. 2004;21(2): 134-5.
20. Buttenschoen K, Kornmann M, Berger D, Leder G, Beger HG, Vasilescu C. Endotoxemia and endotoxin tolerance in patients with ARDS. Langenbecks Arch Surg. 2008;393(4): 473-8.
21. Cross AS. Endotoxin tolerance-current concepts in historical perspective. J Endotoxin Res. 2002;8(2): 83-98.
22. West MA, Heagy W. Endotoxin tolerance: a review. Crit Care Med. 2002;30(1 Supp):S64-S73.
23. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 2009;30(10): 475-87.
24. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007;21(2): 325-32.
25. Amura CR, Silverstein R, Morrison DC. Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies. Infect Immun. 1998;66(11): 5372-8.
26. Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T et al. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J Immunol. 2003;170(1): 508-19.
27. Biswas SK, Tergaonkar V. Myeloid differentiation factor 88-independent Toll-like receptor pathway: Sustaining inflammation or promoting tolerance? Int J Biochem Cell Biol. 2007;39(9): 1582-92. Epub 2007 May 3.
28. Fan H, Cook JA. Molecular mechanisms of endotoxin tolerance. J Endotoxin Res. 2004;10(2): 71-84.
29. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol. 2008;9(8): 839-45.
30. Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care. 2006;10(5): 233.
31. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 2007;179(8): 5082-9.
32. Vasilescu C, Olteanu M, Buttenschoen K, Flondor P. Severe acute pancreatitis between systematic inflammatory response syndrome and sepsis: insights from a mathematical model of endotoxin tolerance. Am J Surg. 2007;194:S33-S38.
33. Vasilescu C, Olteanu M, Flondor P. Fractal-like kinetics, a possible link between preconditioning and sepsis immunodepression. On the chemical basis of innate immunity. Chirurgia (Bucur). 2012;107(1): 22-6.
34. Vasilescu C, Olteanu M, Flondor P. Description of the preconditioning effect in biology by means of fractal-like enzyme kinetics of intracellular reactions. Rev Roum Chim 2011; 56: 751-7.
35. Kehlet H. The surgical stress response: should it be prevented? Can J Surg. 1991;34(6): 565-7.
36. Baigrie RJ, Lamont PM, Kwiatkowski D, Dallman MJ, Morris PJ. Systemic cytokine response after major surgery. Br J Surg. 1992;79(8): 757-60.
37. Vasilescu C, Berger D, Buttenschon K, Seidelmann M, Beger HG. Endotoxin-induced release of interleukin 6 and interleukin 1 beta in human blood is independent of tumor necrosis factor alpha. Eur Surg Res. 1996;28(1): 55-62.
38. Wortel CH, van Deventer SJ, Aarden LA, Lygidakis NJ, Buller HR, Hoek FJ et al. Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery. 1993;114(3): 564-70.
39. Buttenschoen K, Buttenschoen DC, Berger D, Vasilescu C, Schafheutle S, Goeltenboth B et al. Endotoxemia and acutephase proteins in major abdominal surgery. Am J Surg. 2001;181(1): 36-43.
40. Gruys E, Toussaint MJ, Niewold TA, Koopmans SJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B. 2005;6(11): 1045-56.
41. Berger D, Boelke E, Stanescu A, Buttenschoen K, Vasilescu C, Seidelmann M et al. Endotoxemia and mediator release during colonoscopy. Endoscopy. 1995;27(9): 671-5.
42. Vittimberga FJ, Jr., Foley DP, Meyers WC, Callery MP. Laparoscopic surgery and the systemic immune response. Ann Surg. 1998;227(3): 326-34.
43. Vasilescu C, Herlea V, Buttenschoen K, Beger HG. Endotoxin translocation in two models of experimental acute pancreatitis. J Cell Mol Med. 2003;7(4): 417-24.
44. Hewitt PM, Ip SM, Kwok SP, Somers SS, Li K, Leung KL et al. Laparoscopic-assisted vs. open surgery for colorectal cancer: comparative study of immune effects. Dis Colon Rectum. 1998;41(7): 901-9.
45. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest. 2009;136(5 Suppl):e28.
46. Remick DG. Cytokine therapeutics for the treatment of sepsis: why has nothing worked? Curr Pharm Des 2003;9: 75-82.
47. Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol. 2006; 6(11): 813-22. Epub 2006 Oct 13.
48. Hotchkiss RS, Tinsley KW, Swanson PE, Grayson MH, Osborne DF, Wagner TH et al. Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol. 2002; 168(5): 2493-500.
49. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003; 29(4): 530-8. Epub 2003 Mar 28.
50. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One. 2009;4(10):e7405.
51. Gîzǎ DE, Vasilescu C. MicroRNA's role in sepsis and endotoxin tolerance. More players on the stage. Chirurgia (Bucur). 2010;105(5): 625-30. Romanian
52. Nahid MA, Pauley KM, Satoh M, Chan EK. miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. J Biol Chem. 2009;284(50): 34590-9.
53. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5(8): 606-16.
54. Altamura M, Caradonna L, Amati L, Pellegrino NM, Urgesi G, Miniello S. Splenectomy and sepsis: the role of the spleen in the immune-mediated bacterial clearance. Immunopharmacol Immunotoxicol. 2001;23(2): 153-61.
55. Timens W. The human spleen and the immune system: not just another lymphoid organ. Res Immunol. 1991;142(4): 316-20.
56. Jirillo E, Mastronardi ML, Altamura M, Munno I, Miniello S, Urgesi G et al. The immunocompromised host: immune alterations in splenectomized patients and clinical implications. Curr Pharm Des. 2003;9(24): 1918-23.
57. Hebert JC, O'Reilly M, Yuenger K, Shatney L, Yoder DW, Barry B. Augmentation of alveolar macrophage phagocytic activity by granulocyte colony stimulating factor and interleukin-1: influence of splenectomy. J Trauma. 1994;37(6): 909-12.
58. van den Dobbelsteen GP, Brunekreef K, Kroes H, van RN, van Rees EP. Enhanced triggering of mucosal immune responses by reducing splenic phagocytic functions. Eur J Immunol. 1993; 23(7): 1488-93.
59. Okabayashi T, Hanazaki K. Overwhelming postsplenectomy infection syndrome in adults - a clinically preventable disease. World J Gastroenterol. 2008;14(2): 176-9.
60. Medvedev AE, Flo T, Ingalls RR, Golenbock DT, Teti G, Vogel SN et al. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-kappaB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J Immunol. 1998;160(9): 4535-42.
61. Vasilescu C, Stanciulea O, Tudor S, Stanescu D, Colita A, Stoia R et al. Laparoscopic subtotal splenectomy in hereditary spherocytosis : to preserve the upper or the lower pole of the spleen? Surg Endosc. 2006;20(5): 748-52. Epub 2006 Mar 16.
62. Tiron A, Vasilescu C. Role of the spleen in immunity. Immunologic consequences of splenectomy. Chirurgia (Bucur). 2008;103(3): 255-63. Romanian